Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.
- DOI
- 10.1515/jpem-2023-0512
- Published
- 2024 Jun 25
- Container
- Journal of pediatric endocrinology & metabolism : JPEM
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1515/jpem-2023-0512,
title = {Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.},
author = {Gomez R and Khadilkar V and Shembalkar J and Chu DM and Ko CW and Wajnrajch MP and Wang R},
year = {2024},
journal = {Journal of pediatric endocrinology \& metabolism : JPEM},
doi = {10.1515/jpem-2023-0512},
url = {https://doi.org/10.1515/jpem-2023-0512}
}RIS
TY - JOUR TI - Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin. AU - Gomez R AU - Khadilkar V AU - Shembalkar J AU - Chu DM AU - Ko CW AU - Wajnrajch MP AU - Wang R PY - 2024 JO - Journal of pediatric endocrinology & metabolism : JPEM DO - 10.1515/jpem-2023-0512 UR - https://doi.org/10.1515/jpem-2023-0512 ER -
APA
R, G., V, K., J, S., DM, C., CW, K., MP, W., & R, W. (2024). Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.. Journal of pediatric endocrinology & metabolism : JPEM. https://doi.org/10.1515/jpem-2023-0512
Source records
- pubmed · retrieved 2026-09-26T12:06:44.826Z
- europe-pmc · retrieved 2026-09-26T12:06:44.802Z